Beauty Farm Medical and Health Industry Inc. disclosed that on 13 May 2026 it bought back 19,500 ordinary shares on the Hong Kong Stock Exchange for a total consideration of HK$0.38 million. The transaction was executed within a price band of HK$19.13 to HK$19.44 per share, translating into a volume-weighted average cost of HK$19.31 per share.

Following the buyback, the company’s issued share capital (excluding treasury shares) fell marginally by 0.0078% to 249.55 million shares, while treasury shares increased to 2.05 million. The total number of issued shares remained unchanged at 251.59 million.

The repurchase forms part of the mandate granted on 27 June 2025, which authorises Beauty Farm to buy back up to 23.58 million shares. Including the latest transaction, the company has repurchased 2.05 million shares under this mandate, representing 0.87% of the issued share count recorded at the time the resolution was passed.

Under Hong Kong listing rules, Beauty Farm is subject to a moratorium on issuing new shares or disposing of treasury shares until 12 June 2026. The board confirmed that the repurchase complied with all applicable regulations and that all funds due have been fully settled.